Product/Composition | Strength | Form | Category | View/Enquiry |
---|---|---|---|---|
Posaconazole Intravenous (iv) Solution | 300 mg/100 mL | Intravenous (iv) Solution | Anti-fungal | |
Amphotericin B Injectable | 50 mg/vial, 50 mg/mL | Intravenous (iv) Injection | Anti-fungal | |
Liposomal Amphotericin B Injectable | 50 mg/vial | Injection | Anti-fungal | |
Griseofulvin Tablets | 125 mg, 250 mg, 500 mg | Tablets | Anti-fungal | |
Griseofulvin Suspension | 50 mg/5 mL; 125mg/5ml | Suspension | Anti-fungal | |
Clotrimazole Topical Creams/ointments | 1%, 2% | Topical Creams/ointments | Anti-fungal | |
Clotrimazole Vaginal Tablets/cream | 10 mg, 100 mg, 200 mg (vaginal tablets), 1% (cream) | Vaginal Tablets/cream | Anti-fungal | |
Miconazole Vaginal Creams And Suppositories | 2%, 120 mg (vaginal suppositories) | Vaginal Creams And Suppositories | Anti-fungal | |
Miconazole Topical Creams/ointments | 2%, 4% | Topical Creams/ointments | Anti-fungal | |
Terbinafine Tablets | 250 mg | Tablets | Anti-fungal | |
Terbinafine Topical Creams /solutions | 1% cream, 1% solution | Topical Creams /solutions | Anti-fungal | |
Efinaconazole Topical Solution | 10% | Topical Solution | Anti-fungal | |
Caspofungin Intravenous (iv) Powder | 50 mg/vial, 70 mg/vial | Intravenous (iv) Powder | Anti-fungal | |
Anidulafungin Injection | 50 mg/vial | Intravenous (iv) Powder | Anti-fungal | |
Micafungin Intravenous (iv) Powder | 50 mg, 100 mg/vial | Intravenous (iv) Powder | Anti-fungal | |
Nystatin Topical Creams And Ointments | 100,000 units/g, 100,000–300,000 units/g | Topical Creams And Ointments | Anti-fungal | |
Nystatin Oral Suspensions/tablets | Tab: 500,000 units, 1,000,000 units; Sus: 100,000 units/mL, 500,000 units/5 mL | Tablets/suspensions | Anti-fungal |
A pharmaceutical fungicide or fungistatic called an antifungal medicine, also referred to as an antimycotic medication, is used to treat and prevent mycosis, including athlete's foot, ringworm, candidiasis, and dangerous systemic infections such cryptococcal meningitis.
Antifungal drugs often function by either destroying the fungal cells or preventing them from proliferating. The fungal cell wall and membrane are two areas of the cell that antifungal medications target. Similar to how bacteria can become resistant to antibiotics, fungi can also acquire resistance to antifungal medications. Resistance occurs when bacteria learn to evade the medications intended to kill them.